Finance

Lists
Why is RMD up 2,02%?
Dive Deeper
RMD:ASX
Resmed CDI
34,89 AUD
+2,02%
(+0,69) 1D
21-окт., 16:10:19 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RMD...
Open
34,98 AUD
High
35,14 AUD
Low
34,87 AUD
Mkt. cap
34,60 млд
Avg. vol.
1,08 млн
Volume
1,86 млн
52-wk high
41,54 AUD
52-wk low
25,50 AUD
Shares outstanding
140,64 млн
No. of employees
11 миң
Open
34,98 AUD
High
35,14 AUD
Low
34,87 AUD
Mkt. cap
34,60 млд
Avg. vol.
1,08 млн
Volume
1,86 млн
52-wk high
41,54 AUD
52-wk low
25,50 AUD
Shares outstanding
140,64 млн
No. of employees
11 миң
News stories
From web sources and news partners
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed CDI
CEOMichael J. Farrell
Employees11,4 миң
Foundedиюн. 1989
HeadquartersСан Диего, Калифорния, Америка Кошмо Штаттары
SectorMedical device
Websiteresmed.com
Next call 8 күндөн кийин
29-окт., бейш., 22:30
Fiscal period
Q1 2027
- / 0,27 USD
Revenue / Est. (USD)
- / 1,39 млд
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,34 млд
1,42 млд
1,43 млд
1,46 млд
Cost of goods sold
506,94 млн
536,28 млн
532,58 млн
594,13 млн
Cost of revenue
506,94 млн
536,28 млн
532,58 млн
594,13 млн
Research and development expenses
87,32 млн
90,97 млн
94,27 млн
105,72 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
259,19 млн
275,70 млн
279,80 млн
293,36 млн
Operating expense
366,29 млн
386,24 млн
393,16 млн
417,88 млн
Total operating expenses
873,24 млн
922,51 млн
925,74 млн
1,01 млд
Operating income
462,35 млн
500,30 млн
505,67 млн
451,64 млн
Other non operating income
-3,84 млн
42,00 миң
181,00 миң
4,40 млн
EBT including unusual items
446,79 млн
496,15 млн
502,31 млн
474,16 млн
EBT excluding unusual items
468,79 млн
504,48 млн
518,30 млн
476,09 млн
Income tax expense
98,26 млн
103,56 млн
103,58 млн
90,73 млн
Effective tax rate
21,99%
20,87%
20,62%
19,14%
Other operating expenses
-
-
-
-
Net income
348,54 млн
392,59 млн
398,73 млн
383,43 млн
Net profit margin
26,10%
27,59%
27,86%
26,20%
Earnings per share
2,55
2,81
0,29
0,30
Interest and investment income
4,69 млн
4,46 млн
3,80 млн
31,76 млн
Interest expense
-
-
-
-
Net interest expenses
4,69 млн
4,46 млн
3,80 млн
31,76 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
503,64 млн
543,79 млн
558,22 млн
490,13 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору